10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Healthcare-associated infections (HAIs) are a persistent concern in healthcare settings worldwide, representing a significant burden on patient health and healthcare systems. These infections, acquired during the course of medical care, encompass a wide range of conditions, including bloodstream infections, surgical site infections, and healthcare-associated pneumonia. Factors contributing to HAIs may include invasive medical procedures, improper hand hygiene practices, and contaminated medical equipment. Addressing HAIs requires a concerted effort from healthcare professionals, infection control teams, and policymakers to implement evidence-based strategies aimed at reducing transmission and preventing infections. By prioritizing infection prevention and control measures, healthcare facilities can effectively minimize the incidence of HAIs, safeguard patient well-being, and optimize healthcare delivery.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria